Urology

ERBB2-positive bladder cancer showed a 73.1% complete response rate with combination therapy in a phase II trial.

A global registry of 805 patients found transurethral bladder stone surgery was the most common approach, offering high stone clearance and shorter hospital stays, while other techniques were reserved for more complex cases.

A study of 221 male childhood cancer survivors linked pubertal hormone levels with adult fertility outcomes, highlighting persistent impairment after radiotherapy and evidence of hormonal recovery after intermediate-dose chemotherapy.

A learning curve analysis found that surgeons with prior Xi experience adopted single-port robot-assisted radical prostatectomy efficiently, achieving short operative times from the earliest cases.

A multicentre study found a urine methylation assay accurately detected urothelial carcinoma and identified postoperative recurrences months before clinical confirmation.

Gepotidacin was associated with rapid symptom improvement in patients with uncomplicated urinary tract infections, with more than half improving within 24 hours.

A five year analysis found stone recurrence in 35.1% of patients after ureteroscopic lithotripsy, with stone side emerging as the only independent predictor.

Analysis of England’s urology waiting list found major reductions in long wait pathways between 2024 and 2026, while more than one third of pathways remained beyond 18 weeks.